1 Nakata, K., Ito, Y., Magadi, W., Bonaventure, A., Stiller, C. A., Katanoda, K., Matsuda, T., Miyashiro, I., Pritchard-Jones, K., Rachet, B. Childhood cancer incidence and survival in Japan and England: A population-based study (1993-2010). Cancer Sci 109, 422–434 (2018).
2 Hunger, S. P., Mullighan, C. G. Acute Lymphoblastic Leukemia in Children. N Engl J Med 373, 1541-1552 (2015).
3 Inaba, H., Greaves, M., Mullighan, C. G. Acute lymphoblastic leukaemia. Lancet 381, 1943-55 (2013).
4 Zaliova, M., Stuchly, J., Winkowska, L., Musilova, A., Fiser, K., Slamova, M., Starkova, J., Vaskova, M., Hrusak, O., Sramkova, L., Stary, J., Zuna, J., Trka, J. Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort. Haematologica 104, 1396-1406 (2019).
5 Harvey, R. C., Mullighan, C. G., Wang, X., Dobbin, K. K., Davidson, G. S., Bedrick, E. J., Chen, I. M., Atlas, S. R., Kang, H., Ar, K., Wilson, C. S., Wharton, W., Murphy, M., Devidas, M., Carroll, A. J., Borowitz, M. J., Bowman, W. P., Downing, J. R., Relling, M., Yang, J., Bhojwani, D., Carroll, W. L., Camitta, B., Reaman, G. H., Smith, M., Hunger, S. P., Willman, C. L. Identification of novel cluster groups in pediatric highrisk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. Blood 116, 4874-4884 (2010).
6 Roberts, K. G., Li, Y., Payne-Turner, D., Harvey, R. C., Yang, Y. L., Pei, D., McCastlain, K., Ding, L., Lu, C., Song, G., Ma, J., Becksfort, J., Rusch, M., Chen, S. C., Easton, J., Cheng, J., Boggs, K., Santiago-Morales, N., Iacobucci, I., Fulton, R. S., Wen, J., Valentine, M., Cheng, C., Paugh, S. W., Devidas, M., Chen, I. M., Reshmi, S., Smith, A., Hedlund, E., Gupta, P., Nagahawatte, P., Wu, G., Chen, X., Yergeau, D., Vadodaria, B., Mulder, H., Winick, N. J., Larsen, E. C., Carroll, W. L., Heerema, N. A., Carroll, A. J., Grayson, G., Tasian, S. K., Moore, A. S., Keller, F., Frei-Jones, M., Whitlock, J. A., Raetz, E. A., White, D. L., Hughes, T. P., Guidry Auvil, J. M., Smith, M. A., Marcucci, G., Bloomfield, C. D., Mrózek, K., Kohlschmidt, J., Stock, W., Kornblau, S. M., Konopleva, M., Paietta, E., Pui, C. H., Jeha, S., Relling, M. V., Evans, W. E., Gerhard, D. S., Gastier-Foster, J. M., Mardis, E., Wilson, R. K., Loh, M. L., Downing, J. R., Hunger, S. P., Willman, C. L., Zhang, J., Mullighan, C. G. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med 371, 1005-1015 (2014).
7 Wells, J., Jain, N., Konopleva, M. Philadelphia chromosome-like acute lymphoblastic leukemia: progress in a new cancer subtype. Clin Adv Hematol Oncol 15, 554-561 (2017).
8 Ou, Z., Sherer, M., Casey, J., Bakos, H. A., Vitullo, K., Hu, J., Friehling, E., Gollin, S. M. , Surti, U., Yatsenko, S.A. The Genomic Landscape of PAX5, IKZF1, and CDKN2A/B Alterations in B-Cell Precursor Acute Lymphoblastic Leukemia. Cytogenet Genome Res 150, 242-252 (2016).
9 Stanulla, M., Dagdan, E., Zaliova, M., Möricke, A., Palmi, C., Cazzaniga, G., Eckert, C., Te Kronnie, G., Bourquin, J. P., Bornhauser, B., Koehler, R., Bartram, C. R., Ludwig, W. D., Bleckmann, K., Groeneveld-Krentz, S., Schewe, D., Junk, S. V., Hinze, L., Klein, N., Kratz, C. P., Biondi, A., Borkhardt, A., Kulozik, A., Muckenthaler, M. U., Basso ,G., Valsecchi, M. G., Izraeli, S., Petersen, B. S., Franke, A., Dörge, P., Steinemann, D., Haas, O. A., Panzer-Grümayer, R., Cavé, H., Houlston, R. S., Cario, G., Schrappe, M., Zimmermann, M. TRANSCALL Consortium; International BFM Study Group. IKZF1plus Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia. J Clin Oncol 36, 1240-1249 (2018).
10 Churchman, M. L., Qian, M., Te Kronnie, G., Zhang, R., Yang, W., Zhang, H., Lana, T., Tedrick, P., Baskin, R., Verbist, K., Peters, J. L., Devidas, M., Larsen, E., Moore, I. M., Gu, Z., Qu, C., Yoshihara, H., Porter, S. N., Pruett-Miller, S. M., Wu, G., Raetz, E., Martin, P. L., Bowman, W. P., Winick, N., Mardis, E., Fulton, R., Stanulla, M., Evans, W. E., Relling, M. V., Pui, C. H., Hunger, S. P., Loh, M. L., Handgretinger, R., Nichols, K. E., Yang, J. J., Mullighan, C. G. Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia. Cancer Cell 33, 937-948 (2018).
11 Bull, M. J. & Genetics, C. o. Health supervision for children with Down syndrome. Pediatrics 128, 393-406 (2011).
12 Hasle, H., Clemmensen, I. H., Mikkelsen, M. Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet 355, 165-169 (2000).
13 Ito, E., Kasai, M., Hayashi, Y., Toki, T., Arai, K., Yokoyama, S., Kato, K., Tachibana, N., Yamamoto, M., Yokoyama, M. Expression of erythroid-specific genes in acute megakaryoblastic leukaemia and transient myeloproliferative disorder in Down's syndrome. Br J Haematol 90, 607-614 (1995).
14 de Rooij, J. D., Branstetter, C., Ma, J., Li, Y., Walsh, M. P., Cheng, J., Obulkasim, A., Dang, J., Easton, J., Verboon, L. J., Mulder, H. L., Zimmermann, M., Koss, C., Gupta, P., Edmonson, M., Rusch, M., Lim, J. Y., Reinhardt, K., Pigazzi, M., Song, G., Yeoh, A. E., Shih, L. Y., Liang, D. C., Halene, S., Krause, D. S., Zhang, J., Downing, J. R., Locatelli, F., Reinhardt, D., van den Heuvel-Eibrink, M. M., Zwaan, C. M., Fornerod, M., Gruber, T. A. Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes. Nat Genet 49, 451- 456 (2017).
15 Buitenkamp, T. D., Izraeli, S., Zimmermann, M., Forestier, E., Heerema, N. A., van den Heuvel-Eibrink, M. M., Pieters, R., Korbijn, C. M., Silverman, L. B., Schmiegelow, K., Liang, D. C., Horibe, K., Arico, M., Biondi, A., Basso, G., Rabin, K. R., Schrappe, M., Cario, G., Mann, G., Morak, M., Panzer-Grümayer, R., Mondelaers, V., Lammens, T., Cavé, H., Stark, B., Ganmore, I., Moorman, A. V., Vora, A., Hunger, S. P., Pui, C. H., Mullighan, C. G., Manabe, A., Escherich, G., Kowalczyk, J. R., Whitlock, J. A., Zwaan, C. M. Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group. Blood 123, 70-77 (2014).
16 後藤裕明. ダウン症候群に合併した急性リンパ性白血病. J Pediatr Hematol Oncol. 53, 196–202 (2016).
17 Nikolaev, S. I., Garieri, M., Santoni, F., Falconnet, E., Ribaux, P., Guipponi, M., Murray, A., Groet, J., Giarin, E., Basso, G., Nizetic, D., Antonarakis, S. E. Frequent cases of RAS-mutated Down syndrome acute lymphoblastic leukaemia lack JAK2 mutations. Nat Commun 5, 4654 (2014).
18 Lane, A. A., Chapuy, B., Lin, C. Y., Tivey, T., Li, H., Townsend, E. C., van Bodegom, D., Day, T. A., Wu, S. C., Liu, H., Yoda, A., Alexe, G., Schinzel, A. C., Sullivan, T. J., Malinge, S., Taylor, J. E., Stegmaier, K., Jaffe, J. D., Bustin, M., te Kronnie, G., Izraeli, S., Harris, MH., Stevenson, K. E., Neuberg, D., Silverman, L. B., Sallan, S. E., Bradner, J. E., Hahn, W. C., Crispino, J. D., Pellman, D., Weinstock, D. M. Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylation. Nat Genet 46, 618-623 (2014).
19 Thompson, B. J., Bhansali, R., Diebold, L., Cook, D. E., Stolzenburg, L., Casagrande, A. S., Besson, T., Leblond, B., Désiré, L., Malinge, S., Crispino, J. D. DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3. J Exp Med 212, 953-970 (2015).
20 Buitenkamp, T. D., Pieters, R., Gallimore, N. E., van der Veer, A., Meijerink, J. P., Beverloo, H. B., Zimmermann, M., de Haas, V., Richards, S. M., Vora, A. J., Mitchell, C. D., Russell, L. J., Schwab, C., Harrison, C. J., Moorman, A. V., van den HeuvelEibrink, M. M., den Boer, M. L., Zwaan, C. M. Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations. Leukemia 26, 2204-2211 (2012).
21 Hirabayashi, S., Ohki, K., Nakabayashi, K., Ichikawa, H., Momozawa, Y., Okamura, K., Yaguchi, A., Terada, K., Saito, Y., Yoshimi, A., Ogata-Kawata, H., Sakamoto, H., Kato, M., Fujimura, J., Hino, M., Kinoshita, A., Kakuda, H., Kurosawa, H., Kato, K., Kajiwara, R., Moriwaki, K., Morimoto, T., Nakamura, K., Noguchi, Y., Osumi, T., Sakashita, K., Takita, J., Yuza, Y., Matsuda, K., Yoshida, T., Matsumoto, K., Hata, K., Kubo, M., Matsubara, Y., Fukushima, T., Koh, K., Manabe, A, Ohara, A., Kiyokawa, N.; Tokyo Children’s Cancer Study Group (TCCSG). ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype. Haematologica 102, 118-129 (2017).
22 Nordlund, J., Bäcklin, C. L., Wahlberg, P., Busche, S., Berglund, E. C., Eloranta, M. L., Flaegstad, T., Forestier, E., Frost, B. M., Harila-Saari, A., Heyman, M., Jónsson, O. G., Larsson, R., Palle, J., Rönnblom, L., Schmiegelow, K., Sinnett, D., Söderhäll, S., Pastinen, T., Gustafsson, M. G., Lönnerholm, G., Syvänen, A. C. Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia. Genome Biol 14, r105 (2013).
23 Teschendorff, A. E., Marabita, F., Lechner, M., Bartlett, T., Tegner, J., Gomez-Cabrero, D., Beck, S. A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data. Bioinformatics 29, 189-196 (2013).
24 Du, P., Zhang, X., Huang, C. C., Jafari, N., Kibbe, W. A., Hou, L., Lin, S. M. Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics 11, 587 (2010).
25 Yoshida, K., Sanada, M., Shiraishi, Y., Nowak, D., Nagata, Y., Yamamoto, R., Sato, Y., Sato-Otsubo, A., Kon, A., Nagasaki, M., Chalkidis, G., Suzuki, Y., Shiosaka, M., Kawahata, R., Yamaguchi, T., Otsu, M., Obara, N., Sakata-Yanagimoto, M., Ishiyama, K., Mori, H., Nolte, F., Hofmann, W. K., Miyawaki, S., Sugano, S., Haferlach, C., Koeffler, H. P., Shih, L. Y., Haferlach, T., Chiba, S., Nakauchi, H., Miyano, S., Ogawa, S. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 478, 64-69 (2011).
26 Shiraishi, Y., Sato, Y., Chiba, K., Okuno, Y., Nagata, Y., Yoshida, K., Shiba, N., Hayashi, Y., Kume, H., Homma, Y., Sanada, M., Ogawa, S., Miyano, S. An empirical Bayesian framework for somatic mutation detection from cancer genome sequencing data. Nucleic Acids Res 41, e89 (2013).
27 Schwab, C. J., Jones, L.R., Morrison, H., Ryan, S. L., Yigittop, H., Schouten, J. P., Harrison, C. J. Evaluation of multiplex ligation-dependent probe amplification as a method for the detection of copy number abnormalities in B-cell precursor acute lymphoblastic leukemia. Genes Chromosomes Cancer 49, 1104-1113 (2010).
28 Yamamoto, G., Nannya, Y., Kato, M., Sanada, M., Levine, R. L., Kawamata, N., Hangaishi, A., Kurokawa, M., Chiba, S., Gilliland, D. G., Koeffler, H. P., Ogawa S. Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays. Am J Hum Genet 81, 114-126 (2007).
29 Chapiro, E., Russell, L., Radford-Weiss, I., Bastard, C., Lessard, M., Struski, S., Cave, H., Fert-Ferrer, S., Barin, C., Maarek, O., Della-Valle, V., Strefford, J. C., Berger, R., Harrison, C. J., Bernard, O. A., Nguyen-Khac, F. Overexpression of CEBPA resulting from the translocation t(14;19)(q32;q13) of human precursor B acute lymphoblastic leukemia. Blood 108, 3560-3563, doi:10.1182/blood-2006-03-010835 (2006).
30 Messinger, Y. H., Higgins, R. R., Devidas, M., Hunger, S. P., Carroll, A. J., Heerema, N. A. Pediatric acute lymphoblastic leukemia with a t(8;14)(q11.2;q32): B-cell disease with a high proportion of Down syndrome: a Children's Oncology Group study. Cancer Genet 205, 453-458, doi:10.1016/j.cancergen.2012.07.016 (2012).
31 Pui, C. H., Raimondi, S. C., Borowitz, M. J., Land, V. J., Behm, F. G., Pullen, D. J., Hancock, M. L., Shuster, J. J., Steuber, C. P., Crist, W.M. Immunophenotypes and karyotypes of leukemic cells in children with Down syndrome and acute lymphoblastic leukemia. J Clin Oncol 11, 1361-1367, doi:10.1200/JCO.1993.11.7.1361 (1993).
32 Bacalini, M. G., Gentilini, D., Boattini, A., Giampieri, E., Pirazzini, C., Giuliani, C., Fontanesi, E., Scurti, M., Remondini, D., Capri, M., Cocchi, G., Ghezzo, A., Del Rio, A., Luiselli, D., Vitale, G., Mari, D., Castellani, G., Fraga, M., Di Blasio, A. M., Salvioli, S., Franceschi, C., Garagnani, P. Identification of a DNA methylation signature in blood cells from persons with Down Syndrome. Aging (Albany NY) 7, 82-96, doi:10.18632/aging.100715 (2015).
33 Lee, A. S., Tang, C., Rao, M. S., Weissman, I. L., Wu, J. C. Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies. Nat Med 19, 998-1004, doi:10.1038/nm.3267 (2013).
34 Ley, T. J., Miller, C., Ding, L., Raphael, B. J., Mungall, A. J., Robertson, A., Hoadley, K., Triche, T. J. Jr, Laird, P. W., Baty, J. D., Fulton, L. L., Fulton, R., Heath, S. E., Kalicki-Veizer, J., Kandoth, C., Klco, J. M., Koboldt, D. C., Kanchi, K. L., Kulkarni, S., Lamprecht, T. L., Larson, D. E., Lin, L., Lu, C., McLellan, M. D., McMichael, J. F., Payton, J., Schmidt, H., Spencer, D. H., Tomasson, M. H., Wallis, J. W., Wartman, L. D., Watson, M. A., Welch, J., Wendl, M. C., Ally, A., Balasundaram, M., Birol, I., Butterfield, Y., Chiu, R., Chu, A., Chuah, E., Chun, H. J., Corbett, R., Dhalla, N., Guin, R., He, A., Hirst, C., Hirst, M., Holt, R. A., Jones, S., Karsan, A., Lee, D., Li, H. I., Marra, M. A., Mayo, M., Moore, R. A., Mungall, K., Parker, J., Pleasance, E., Plettner, P., Schein, J., Stoll, D., Swanson, L., Tam, A., Thiessen, N., Varhol, R., Wye, N., Zhao, Y., Gabriel, S., Getz, G., Sougnez, C., Zou, L., Leiserson, M. D., Vandin, F., Wu, H. T., Applebaum, F., Baylin, S. B., Akbani, R., Broom, B. M., Chen, K., Motter, T. C., Nguyen, K., Weinstein, J. N., Zhang, N., Ferguson, M. L., Adams, C., Black, A., Bowen, J., Gastier-Foster, J., Grossman, T., Lichtenberg, T., Wise, L., Davidsen, T., Demchok, J. A., Shaw, K. R., Sheth, M., Sofia, H. J., Yang, L., Downing, J. R., Eley, G. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 368, 2059-2074, doi:10.1056/NEJMoa1301689 (2013).
35 Martinez, M., Hinojosa, M., Trombly, D., Morin, V., Stein, J., Stein, G., Javed, A., Gutierrez, S. E. Transcriptional Auto-Regulation of RUNX1 P1 Promoter. PLoS One 11, e0149119, doi:10.1371/journal.pone.0149119 (2016).
36 Ofverholm, I., Tran, A. N., Heyman, M., Zachariadis, V., Nordenskjöld, M., Nordgren, A., Barbany, G. Impact of IKZF1 deletions and PAX5 amplifications in pediatric B-cell precursor ALL treated according to NOPHO protocols. Leukemia 27, 1936-1939, doi:10.1038/leu.2013.92 (2013).
37 Gu, Z., Churchman, M. L., Roberts, K. G., Moore, I., Zhou, X., Nakitandwe, J., Hagiwara, K., Pelletier, S., Gingras, S., Berns, H., Payne-Turner, D., Hill, A., Iacobucci, I., Shi, L., Pounds, S., Cheng, C., Pei, D., Qu, C., Newman, S., Devidas, M., Dai, Y., Reshmi, S. C., Gastier-Foster, J., Raetz, E. A., Borowitz, M. J., Wood, B. L., Carroll, W. L., Zweidler-McKay, P. A., Rabin, K. R., Mattano, L. A., Maloney, K. W., Rambaldi, A., Spinelli, O., Radich, J. P., Minden, M. D., Rowe, J. M., Luger, S., Litzow, M. R., Tallman, M. S., Racevskis, J., Zhang, Y., Bhatia, R., Kohlschmidt, J., Mrózek, K., Bloomfield, C. D., Stock, W., Kornblau, S., Kantarjian, H. M., Konopleva, M., Evans, W. E., Jeha, S., Pui, C. H., Yang, J., Paietta, E., Downing, J. R., Relling, M. V., Zhang, J., Loh, M. L., Hunger, S. P., Mullighan, C. G. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. Nat Genet 51, 296-307, doi:10.1038/s41588-018-0315- 5 (2019).
38 Lilljebjörn, H., Henningsson, R., Hyrenius-Wittsten, A., Olsson, L., Orsmark-Pietras, C., von Palffy, S., Askmyr, M., Rissler, M., Schrappe, M., Cario, G., Castor, A., Pronk, C. J., Behrendtz, M., Mitelman, F., Johansson, B., Paulsson, K., Andersson, A. K., Fontes, M., Fioretos, T. Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia. Nat Commun 7, 11790, doi:10.1038/ncomms11790 (2016).
39 Zaliova, M., Kotrova, M., Bresolin, S., Stuchly, J., Stary, J., Hrusak, O., Te Kronnie, G., Trka, J., Zuna, J., Vaskova, M. ETV6/RUNX1-like acute lymphoblastic leukemia: A novel B-cell precursor leukemia subtype associated with the CD27/CD44 immunophenotype. Genes Chromosomes Cancer 56, 608-616, doi:10.1002/gcc.22464 (2017).
40 Paulsson, K., Horvat, A., Strömbeck, B., Nilsson, F., Heldrup, J., Behrendtz, M., Forestier, E., Andersson, A., Fioretos, T., Johansson, B. Mutations of FLT3, NRAS, KRAS, and PTPN11 are frequent and possibly mutually exclusive in high hyperdiploid childhood acute lymphoblastic leukemia. Genes Chromosomes Cancer 47, 26-33, doi:10.1002/gcc.20502 (2008).
41 Webber, B. R., Iacovino, M., Choi, S. H., Tolar, J., Kyba, M., Blazar, B. R. DNA methylation of Runx1 regulatory regions correlates with transition from primitive to definitive hematopoietic potential in vitro and in vivo. Blood 122, 2978-2986, doi:10.1182/blood-2013-03-489369 (2013).
42 Hadi, E., Sharony, R., Goldberg-Bittman, L., Biron-Shental, T., Fejgin, M., Amiel, A. Telomere aggregates in trisomy 21 amniocytes. Cancer Genet Cytogenet 195, 23-26, doi:10.1016/j.cancergencyto.2009.03.003 (2009).
43 Malinge, S., Chlon, T., Doré, L. C., Ketterling, R. P., Tallman, M. S., Paietta, E., Gamis, A. S., Taub, J. W., Chou, S. T., Weiss, M. J., Crispino, J. D., Figueroa, M. E. Development of acute megakaryoblastic leukemia in Down syndrome is associated with sequential epigenetic changes. Blood 122, e33-43, doi:10.1182/blood-2013-05-503011 (2013).